LifeStance holder plans sale of 12,165 shares

LifeStance Health Group Inc. has a stockholder planning to sell 12,165 shares of common stock on NASDAQ through Citadel Securities LLC, located in Miami, Florida.

Rhea-AI Filing Summary

LifeStance Health Group Inc. has a stockholder planning to sell 12,165 shares of common stock on NASDAQ through Citadel Securities LLC, located in Miami, Florida. The proposed sale has an aggregate market value of $129,192.30, with 382,055,609 common shares of the issuer outstanding. The seller previously acquired 206,219 equity interests in LifeStance Health Group Inc. in a pre-IPO transaction dated June 10, 2021. The planned sale date is stated as August 10, 2026.

Key Figures

Shares to be sold: 12,165 shares Aggregate market value: $129,192.30 Shares outstanding: 382,055,609 shares +2 more

5 metrics

Shares to be sold 12,165 shares Planned sale of common stock under Form 144

Aggregate market value $129,192.30 Value of 12,165 shares of common stock to be sold

Shares outstanding 382,055,609 shares Issuer’s common stock outstanding at the time of the notice

Pre-IPO equity interests purchased 206,219 Equity interests acquired in pre-IPO transactions on June 10, 2021

Planned sale date August 10, 2026 Date listed for the proposed NASDAQ sale

Key Terms

Common Stock, Pre-IPO Transactions, equity interests

3 terms

Common Stock financial

"Common Stock | Citadel Securities LLC 830 Brickell Plaza"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Pre-IPO Transactions financial

"Common Stock | 06/10/2021 | Pre-IPO Transactions | LifeStance"

equity interests financial

"Equity interests in the Issuer were purchased pre-IPO."

Equity interests are an ownership stake in a company—usually represented by shares or membership units—that give the holder a claim on the business’s profits, assets and sometimes voting power. Think of it as owning one or more slices of a company’s pie: the bigger your slice, the larger your share of dividends, capital gains and influence, and the more you are affected by dilution or company losses. Investors use equity interests to measure value, control and potential returns.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does LifeStance Health Group (LFST) report in this Form 144?

LifeStance Health Group Inc. reports a planned sale of 12,165 shares of its common stock, with an aggregate market value of $129,192.30, by an existing stockholder under Rule 144 resale provisions.

How many LifeStance Health Group (LFST) shares are planned to be sold?

A stockholder plans to sell 12,165 shares of LifeStance Health Group Inc. common stock. The filing also notes that the issuer has 382,055,609 shares of common stock outstanding as context for the size of the planned sale.

What is the value of the planned LFST stock sale under this Form 144?

The planned sale covers $129,192.30 in aggregate market value of LifeStance Health Group Inc. common stock. This amount corresponds to the proposed sale of 12,165 shares to be transacted on NASDAQ through Citadel Securities LLC.

When were the LFST equity interests originally acquired by the selling stockholder?

The filing states that 206,219 equity interests in LifeStance Health Group Inc. were purchased in pre-IPO transactions on June 10, 2021. The currently planned sale of 12,165 common shares relates to these earlier pre-IPO acquisitions.

When is the planned sale date for the LFST shares in this notice?

The planned sale date for the LifeStance Health Group Inc. shares is listed as August 10, 2026. The shares are expected to be sold on NASDAQ, with Citadel Securities LLC acting in connection with the transaction.

How many LifeStance Health Group (LFST) shares are outstanding according to this filing?

The filing reports that LifeStance Health Group Inc. has 382,055,609 shares of common stock outstanding. This figure provides context for evaluating the relative size of the planned sale of 12,165 shares by an existing holder.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 04:05 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001654074
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LIFESTANCE HEALTH GROUP, INC.
SEC File Number	001-40478
Address of Issuer	4800 N. SCOTTSDALE ROAD SUITE 2500 SCOTTSDALE ARIZONA 85251
Phone	6027672100
Name of Person for Whose Account the Securities are To Be Sold	Summit Investors GE IX-VC IV, LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Owner

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Citadel Securities LLC 830 Brickell Plaza, Floor 15 Miami FL 33131	12165	129192.30	382055609	08/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/10/2021	Pre-IPO Transactions	LifeStance Health Group Inc.			206219	06/10/2021	Equity interests in the Issuer were purchased pre-IPO.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Adam H. Hennessey
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)